{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:13:04Z","timestamp":1788235984298,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijgc.2025.102010","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:49:18Z","timestamp":1752601758000},"page":"102010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive genomic profiling and clinico-pathologic characterization of primary ovarian leiomyosarcoma"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4372-4220","authenticated-orcid":false,"given":"Matteo","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0780-0153","authenticated-orcid":false,"given":"Elisa","family":"De Paolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Minucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-4952","authenticated-orcid":false,"given":"Alessia","family":"Piermattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Maneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-5152","authenticated-orcid":false,"given":"Angela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GianFranco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-5859","authenticated-orcid":false,"given":"Carolina Maria","family":"Sassu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Nero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-8956","authenticated-orcid":false,"given":"Claudia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-335X","authenticated-orcid":false,"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13691-017-0309-7","article-title":"Gemcitabine and docetaxel in a patient with primary ovarian leiomyosarcoma: a case report and review of literature","volume":"7","author":"Furutake","year":"2018","journal-title":"Int Cancer Conf J"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102010_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.ogx.0000268629.16151.71","article-title":"Primary ovarian leiomyosarcoma: a review of the clinical and immunohistochemical features of the rare tumor","volume":"62","author":"Ta\u015fkin","year":"2007","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102010_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ygyno.2005.02.008","article-title":"Epithelioid leiomyosarcoma of the ovary","volume":"97","author":"Bouie","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2025.102010_bib4","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.3390\/cancers15112953","article-title":"Primary ovarian leiomyosarcoma is a very rare entity: a narrative review of the literature","volume":"15","author":"Mandato","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102010_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101825","article-title":"Primary leiomyosarcoma of the ovary: a report of three cases and a systematic review of literature","volume":"50","author":"Yuksel","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ijgc.2025.102010_bib6","article-title":"Clinical management and outcomes of primary ovarian leiomyosarcoma - Experience from a sarcoma specialist unit","volume":"36","author":"Cojocaru","year":"2021","journal-title":"Gynecol Oncol Rep"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102010_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101692","article-title":"Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement \u2013 OSAMA Study)","volume":"35","author":"Ferraioli","year":"2025","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s40792-019-0679-5","article-title":"Vascular leiomyosarcoma originating from the right ovarian vein: a case report and literature review","volume":"5","author":"Hirano","year":"2019","journal-title":"Surg Case Rep"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102010_bib10","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas","volume":"24","author":"Hensley","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.102010_bib11","volume":"4","year":"2020"},{"issue":"24","key":"10.1016\/j.ijgc.2025.102010_bib12","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.3390\/cancers14246152","article-title":"A computational framework for comprehensive genomic profiling in solid cancers: the analytical performance of a high-throughput assay for small and copy number variants","volume":"14","author":"Giac\u00f2","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102010_bib14","first-page":"7303","article-title":"Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages: a single-center case-control matched study","volume":"34","author":"Bacalbasa","year":"2014","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102010_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2021.09.014","article-title":"Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry","volume":"163","author":"Ha","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102010_bib16","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/cancers14081934","article-title":"Role of homologous recombination repair (HRR) genes in uterine leiomyosarcomas: a retrospective analysis","volume":"14","author":"Ciccarone","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102010_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"M\u00e4kinen","year":"2016","journal-title":"PLoS Genet"},{"issue":"15","key":"10.1016\/j.ijgc.2025.102010_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025182118","article-title":"Integrated mutational landscape analysis of uterine leiomyosarcomas","volume":"118","author":"Choi","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"14","key":"10.1016\/j.ijgc.2025.102010_bib20","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-19-3959","article-title":"Genomic landscape of uterine sarcomas defined through prospective clinical sequencing","volume":"26","author":"Hensley","year":"2020","journal-title":"Clin Cancer Res."},{"issue":"4","key":"10.1016\/j.ijgc.2025.102010_bib21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102010_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/cancers15072099","article-title":"Targeting the molecular and immunologic features of leiomyosarcoma","volume":"15","author":"Cope","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.ijgc.2025.102010_bib23","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.33542","article-title":"Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas","volume":"127","author":"Schaefer","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ijgc.2025.102010_bib24","article-title":"Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes","volume":"4","author":"Rosenbaum","year":"2020","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102010_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1634\/theoncologist.2018-0448","article-title":"BRCA1\/2 functional loss defines a targetable subset in leiomyosarcoma","volume":"24","author":"Seligson","year":"2019","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102010_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.seminoncol.2020.10.002","article-title":"Homologous recombination repair deficiency as a therapeutic target in sarcoma","volume":"47","author":"Oza","year":"2020","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2025.102010_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037423","article-title":"Efficacy of tyrosine kinase inhibitors in patients with advanced or metastatic sarcomas after prior chemotherapy: a meta-analysis","volume":"103","author":"Li","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.juro.2015.01.073","article-title":"FGF7 over expression is an independent prognosticator in patients with urothelial carcinoma of the upper urinary tract and bladder","volume":"194","author":"Fan","year":"2015","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102010_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mc.22476","article-title":"Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: a subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies","volume":"56","author":"Mizukami","year":"2017","journal-title":"Mol Carcinog"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102010_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7150\/jca.36316","article-title":"FGF14 functions as a tumor suppressor through inhibiting PI3K\/AKT\/mTOR pathway in colorectal cancer","volume":"11","author":"Su","year":"2020","journal-title":"J Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25011302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25011302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:13:48Z","timestamp":1788232428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25011302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1048891X25011302"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102010","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive genomic profiling and clinico-pathologic characterization of primary ovarian leiomyosarcoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102010"}}